Answers are grounded in this paper and cite their sources.
Introduction: Toxoplasma gondii is a parasite of the protozoan type and is intracellular. These parasites can cause the occurrence of toxoplasmosis in infected individuals. These protozoa are zoonotic and have a global prevalence. The method of enforcing diagnosis in this parasite serologically, molecularly, and microscopically has limitations, namely in the values of sensitivity, specificity, and feasibility. Dense Granule Antigen 7 (GRA 7), which is a protein secreted by T. gondii during the infection stage in the acute and chronic phases, can elicit a strong immune response, so GRA 7 can be used as a biomarker and is very promising. Methods: This study used a method in the form of in silico. This method was performed to characterize the physiochemical properties, secondary and tertiary structures, post-translational modification, and immunogenic epitopes of GRA7. Results: In silico analysis found that GRA7 is hydrophilic. In terms of structural stability, GRA 7 is dominated by alpha-helix. Furthermore, GRA7 contains a transmembrane domain and several predicted epitope regions that may be recognized by B cells and T cells. All of these findings support that GRA7 has the potential to be a potent antigen. In addition, the recombinant productivity of GRA7 increases its application as a diagnostic and on a wide scale. Conclusions: Overall, GRA7 shows strong potential as a reliable antigen for serological diagnosis of toxoplasmosis due to its Received: xx xx, 2026, Revised: xx xx, 2026, Accepted: x 13, 2026, ePublished: xx xx, 2026 high sensitivity and specificity, especially among vulnerable groups such as pregnant women and individuals with weakened immune systems.
No takes yet. Share an insight, caveat, or question.
Fadilla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: